Newronika’s aDBS system secures CE mark with cloud data integration

Newronika has secured the CE mark for the latest commercial version of its αDBS adaptive deep brain stimulation system. The αDBS device transmits the neural data directly into an integrated cloud platform. αDBS is intended to interpret brain signals and adapt therapy accordingly. Credit: mi_viri / Shutterstock.com. Italian medtech company Newronika has secured the CE mark for the latest commercial version of αDBS, its adaptive deep brain stimulation (aDBS) system. The newly approved system comes with full integration to WebBioBank, Newronika’s proprietary cloud-based platform for neural data. Non-Invasive Ventilation Masks and Circuits Market Size (Value, Vol... Go deeper with GlobalData…

Source: Medical Device Network